Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020 08:05 ET
|
Novan, Inc.
- Live video webcast with President and CEO, Paula Brown Stafford, on Monday, September 14th at 4:00 PM EDT - MORRISVILLE, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or...
Novan Announces First Patient Enrolled and Dosed in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
September 03, 2020 09:05 ET
|
Novan, Inc.
- Topline results targeted for Q2 2021, less than a year away - - SB206, if approved, has the potential to meet an important need for the treatment of molluscum, an area with no current FDA-approved...
Novan Initiates B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
August 31, 2020 08:05 ET
|
Novan, Inc.
- Clinical sites actively enrolling patients - - SB206, if approved, has the potential to meet an important need for the treatment of molluscum, an area with no current FDA-approved treatment - ...
Novan President and CEO, Paula Brown Stafford Named Chairman of the Board
July 28, 2020 08:05 ET
|
Novan, Inc.
Expanded role of Ms. Stafford as Chairman reflects the Board’s confidence in her leadership of the Company and strategic direction Renowned pharmaceutical executive Robert Ingram retiring as Executive...
Novan to Host Live Audio Webcast of 2020 Annual Meeting of Stockholders
July 23, 2020 08:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2020 Annual...
Origin files patent application to protect its proposed treatment for viral and bacterial respiratory infections
March 24, 2020 07:00 ET
|
Origin
PRINCETON, N.J., March 24, 2020 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it has filed a provisional U.S. patent application to enhance...
Novan Announces Planned Chief Executive Officer Transition
December 18, 2019 08:00 ET
|
Novan, Inc.
Paula Brown Stafford appointed as CEO effective February 2, 2020G. Kelly Martin’s term as CEO will end on February 1, 2020, per his employment contractMr. Martin will step down from the Novan Board of...
Novan Expands External Business Partner Network
June 19, 2019 08:15 ET
|
Novan, Inc.
Expansion of the existing relationship with MedPharm around formulation scienceManufacturing agreement established for production of proprietary drug substancePartner network now includes those...
Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
May 07, 2019 16:15 ET
|
Novan, Inc.
MORRISVILLE, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that recent data from the Company’s Phase 1b trial with SB414 cream for the...
Novan Completes Funding Transaction with Ligand Pharmaceuticals
May 06, 2019 09:00 ET
|
Novan, Inc.
Novan to immediately receive $12 million of non-dilutive capitalLigand to receive milestones and tiered royalty for North America SB206 molluscum indicationPhase 3 molluscum trial to begin recruitment...